Predicting outcomes in atrial fibrillation and heart failure
Part of Heart & circulation clinical trials.
This study looks at people with both atrial fibrillation and heart failure to see how they do after a heart procedure called ablation. It aims to find better ways to predict outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have persistent atrial fibrillation (AF) that causes symptoms.
- Your heart's pumping ability (ejection fraction) is 40% or less.
- You have heart failure symptoms like shortness of breath or fatigue during daily activities.
- You are already taking all standard heart failure medications.
- You plan to have a catheter ablation procedure for your AF.
- You are between 18 and 80 years old.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a procedure called catheter ablation (which fixes the heart's electrical signals) can help people with heart failure and atrial fibrillation. It focuses on those whose heart pumping strength is mildly reduced or preserved (above 40%).
This trial tests whether early catheter ablation (a procedure to fix irregular heartbeats) helps people who have both heart failure and atrial fibrillation. It looks at how this treatment affects your heart function and quality of life.
This study tests whether a catheter ablation procedure can help people with atrial fibrillation and a kind of heart failure where the heart pumps normally but doesn't relax properly (HFpEF). It looks at whether the procedure can improve symptoms and heart function.
This trial tests whether a catheter procedure that treats atrial fibrillation works better than standard care for people with heart failure with preserved ejection fraction. It aims to improve heart rhythm symptoms and overall outcomes compared with conventional treatment.
This study follows people after a procedure called catheter ablation to treat atrial fibrillation (an irregular heart rhythm). It aims to learn which factors help predict outcomes, so future care can be better tailored.
This trial looks at whether a special heart rhythm treatment called “ablation” works well when done during certain heart operations. It may help reduce atrial fibrillation (AF) symptoms or future abnormal rhythm episodes for people who are already having surgery.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.